Koshinski Asset Management
BIOL

Koshinski Asset Management’s Biolase, Inc. BIOL Stock Holding History

Koshinski Asset Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed -$1.06K – 2054
2022
Q1 		$1.06K Hold
1
– – ﹤0.01% 2056
2021
Q4 		$1.17K Buy
+1
New +$1.26K ﹤0.01% 2063

Other funds holding BIOL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Koshinski Asset Management's BIOL Position: Q2 2022 in Review

Koshinski Asset Management sold out of Biolase, Inc. (BIOL) in Q2 2022, closing a stake of 1 share — an estimated $1.06K sold.

Koshinski Asset Management first reported a position in BIOL in Q4 2021 and held it in 2 quarters. The position peaked at $1.17K in Q4 2021. 16 funds tracked by Wall St. Rank hold BIOL as of Q2 2022.

  • Koshinski Asset Management reported no remaining Biolase, Inc. position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 1 Biolase, Inc. share in Q2 2022, an estimated $1.06K.
  • Koshinski Asset Management first reported a position in Biolase, Inc. in Q4 2021 and held it in 2 quarters.
  • Koshinski Asset Management's Biolase, Inc. position peaked at $1.17K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.